Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;40(2):320-322.
doi: 10.1111/pde.15146. Epub 2022 Oct 21.

Atopic dermatitis-like graft-versus-host disease treated with dupilumab

Mary Larijani  1   2 , Diana Zarowin  3 , Anne Wohlschlaeger  4 , Marissa J Perman  1   2 , James R Treat  1   2
Affiliations

Atopic dermatitis-like graft-versus-host disease treated with dupilumab

Mary Larijani et al. Pediatr Dermatol. 2023 Mar.

Abstract

The mainstay of treatment for atopic dermatitis (AD)-like graft-versus-host disease (GVHD) in both pediatric and adult patients includes oral corticosteroids with or without other systemic immunosuppressive therapies. To our knowledge, we report the first case series of dupilumab in the treatment of AD-like GVHD in a pediatric cohort of four patients, where we observed clinical improvement of GVHD as well as a reduction in itch in 3/4 (75%) patients. Our findings suggest that dupilumab is not only effective in treating AD-like GVHD, but also reduces systemic immunosuppression in the pediatric transplant population. The ability to reduce the length and amount of immunosuppression as well as improve quality of life suggest that dupilumab may serve as a safe and effective therapeutic option in our transplant population with GVHD.

Keywords: atopic dermatitis; skin signs of systemic disease; therapy-systemic.

PubMed Disclaimer

References

REFERENCES

    1. Chong JH, Tawng K, Liew HM, Soh SY, Tan AM, Koh MJ. A case of Eczematoid graft-versus-host disease. Pediatr Dermatol. 2016;33(3):e195-e197.
    1. Li K, Mu Z, Wen G, Zhao Y, Cong X, Zhang J. Increased regulatory T cells and eosinophils characterize atopic dermatitis-like graft-versus-host disease compared with lichen planus-like graft-versus-host disease. J Am Acad Dermatol. 2020;83(3):824-831.
    1. Wei J, Zhang Y, Xu H, Jin J, Zhang J. Atopic dermatitis-like presentation of graft-versus-host disease: a novel form of chronic cutaneous graft-versus-host disease. J Am Acad Dermatol. 2013;69(1):34-39.
    1. Nanda A, Husain MAA, Al-Herz W, Almekaimi A, Al-Sabah H, Al-Otaibi M. Chronic cutaneous graft-versus-host disease in children: a report of 14 patients from a tertiary care pediatric dermatology clinic. Pediatr Dermatol. 2018;35(3):343-353.
    1. Creamer D, Martyn-Simmons CL, Osborne G, et al. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Arch Dermatol. 2007;143(9):1157-1162.

Substances

LinkOut - more resources